IRPSY yields 0.64% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, IRPSY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IRPSY + MRK for your $10,000?
IRPC Public Company Limited, together with its subsidiaries, provides petroleum and petrochemical products in Thailand, Singapore, and internationally. The company operates through Petroleum Products, Petrochemical Products, and Other Business segments. It offers petroleum products, including liquefied petroleum gas, gasohol, gasoline base, diesel, diesel base, gasoline, fuel oil, lube base oil, slack wax, aromatic extract, treated distillate aromatic extract and residue aromatic extract, asphalt, straight-run fuel oil, white spirit, C9 aromatic/aromatic, toluene, xylene, mixed xylenes; and polyethylene, polypropylene, acrylonitrile-butadiene-styrene, acrylonitrile styrene, polystyrene, expandable polystyrene, and additives. It also generates and distributes electricity, power, steam, industrial water, and air systems; and wastewater treatment services for industrial customers. In addition, the company offers port and tank services, such as tugboats, piloting services, lighters, fresh water and fuel, weigh scales, container yards, warehouses, and machines and equipment for the transshipment of goods. Further, it is involved in the provision of asset management and oil vessel renting services; manufacture and distribution of plastic resins; operation of vocational schools; distribution of non-woven fabric products and medical consumables; and distribution of petrochemical products, as well as power plant, jetty, and other utilities operations. The company was formerly known as Thai Petrochemical Industry Public Company Limited and changed its name to IRPC Public Company Limited in October 2006. IRPC Public Company Limited was incorporated in 1978 and is headquartered in Rayong, Thailand.
Full IRPSY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.